PAUSE-500 contains tranexamic acid, an antifibrinolytic agent that helps prevent the breakdown of blood clots and reduces excessive bleeding. The medication stabilizes the blood clotting process and is widely used in gynecology, surgery, dentistry, and trauma care.
Recommended for:
Tranexamic acid has been extensively evaluated in international clinical studies. Research has confirmed its effectiveness in reducing blood loss during menorrhagia, surgery, and trauma management. Major studies, including the CRASH-2 trial, demonstrated reduced mortality risk from severe bleeding when tranexamic acid was administered promptly in trauma patients. The medication is included in international bleeding management guidelines.
The medication is indicated for the prevention and treatment of bleeding associated with increased fibrinolysis. It is used in menorrhagia, postoperative bleeding, trauma, dental procedures, and other conditions involving excessive bleeding. Tranexamic acid helps reduce blood loss and stabilize hemostasis.
The medication should be taken orally as prescribed by a physician. Dosage and duration of therapy depend on the cause and severity of bleeding. Tablets should be taken with sufficient water. During prolonged therapy, monitoring of coagulation status may be required.
Contraindications:
Side effects:
